Tomoko Namba

ナンバトモコ | Tomoko Namba

Affiliation and department：

Research field (1)： Nephrology

Research theme for competitive and other funds (6)：

2022 - 2025 Dapagliflozin preserves allograft function in kidney transplant recipients (KTRs).
2022 - 2025 腎移植後拒絶反応の診断および治療効果予測のための革新的新規バイオマーカーの創出
2021 - 2024 The investigation of innovative methods for antibody-mediated rejection after kidney transplantation
2019 - 2022 Estimation of renal outcome in kidney donors with renal biopsy
2017 - 2019 Potential effect of active vitamin D analogue as an adjuvant therapy for Fabry disease: from the point of autophagy

Show all

Papers (148)：

Shihomi Maeda, Shinsuke Sakai, Yoshitsugu Takabatake, Takeshi Yamamoto, Satoshi Minami, Jun Nakamura, Tomoko Namba-Hamano, Atsushi Takahashi, Jun Matsuda, Hiroaki Yonishi, et al. MondoA and AKI and AKI-to-CKD Transition. Journal of the American Society of Nephrology : JASN. 2024
Satoshi Minami, Shinsuke Sakai, Takeshi Yamamoto, Yoshitsugu Takabatake, Tomoko Namba-Hamano, Atsushi Takahashi, Jun Matsuda, Hiroaki Yonishi, Jun Nakamura, Shihomi Maeda, et al. FGF21 and autophagy coordinately counteract kidney disease progression during aging and obesity. Autophagy. 2023
Madoka Morimoto, Tomoko Namba-Hamano, Shoki Notsu, Yukimasa Iwata, Yumiko Yasuhara, Masafumi Yamato, Yoshitaka Isaka. Diabetic nephropathy with marked extra-capillary cell proliferation: a case report. BMC nephrology. 2023. 24. 1. 139-139
前田志穂美, 酒井晋介, 山本毅士, 高橋篤史, 難波倫子, 松田潤, 南聡, 中村隼, 松井翔, 島田直幸, et al. MondoAはTFEB活性化を介したミトコンドリア生合成によりAKIからCKDへの進展を抑制する. 日本腎臓学会誌. 2023. 65. 3. 247-247
山本毅士, 南聡, 酒井晋介, 高橋篤史, 難波倫子, 松田潤, 余西洋明, 中村隼, 前田志穂美, 松井翔, et al. FGF21とオートファジーは協調的に加齢や肥満による腎臓病進展に対抗する. 日本腎臓学会誌. 2023. 65. 3. 253-253

ｍore...

MISC (22)：

ｍore...

Professional career (1)：

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page